
|Articles|November 15, 2010
Novel ablation profile shows promise for myopic LASIK
A study evaluating outcomes in eyes undergoing LASIK for >-4 D of myopia reaffirms the established efficacy, safety and predictability of treatments performed with the wavefront-optimized, wavefront-guided and topography-guided ablation profiles of an excimer laser.
Advertisement
The Allegretto WFG treatments were performed using data obtained with a Tscherning aberrometer and the T-CAT treatments used data from either Placido-disc (Topolyzer, WaveLight) or Scheimpflug (Oculyzer, WaveLight) technology. Both the 200-Hz (WaveLight Allegretto) and 400-Hz (WaveLight Allegretto Eye-Q) lasers were used for the treatments although the RT treatments all were performed on the 400-Hz laser.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA guidance to help accelerate cell and gene therapies
2
Oculis phase 3 DIAMOND trials miss vision endpoints in diabetic macular edema
3
TearSolutions advances Lacripep into phase 2 following dual FDA designations in neurotrophic keratitis
4
The Residency Report: Cardiovascular risk scores as a window into ocular disease
5





















